Published in American Journal of Clinical Nutrition, study shows memory loss was 3.1 yrs lower in those taking multivitamins. But independent researchers say 'further trials required'.
After Lecanemab, a monoclonal antibody medication for Alzheime's, Eli Lilly and Co. too reported promising phase 3 trial results of its drug, Donanenab, for the disease.
While lecanemab saw less decline in cognition and function of patients, the drug is effective only at a very early stage -- closer to the onset of the disease.
Scientists from University of Wisconsin-Madison, also identified the selective serotonin reuptake inhibitor antidepressant Fluoxetine as being helpful, especially when combined with exercise.
Study by Northwestern University team published in Journal of Neuroscience. SuperAgers have larger neurons than those with early-stage Alzheimer’s & people 2-3 decades younger, it says.
US FDA has approved Aduhelm drug, which proposes to work by chipping away at protein deposits in the brain that cause memory loss and other symptoms of Alzheimer’s.
The new drug, which Biogen developed with Japan's Eisai Co., did not reverse mental decline, but only slowed it in one study. The drug is given as an infusion every four weeks.
The findings were revealed at the Alzheimer’s Association International Conference and the American Heart Association’s Basic Cardiovascular Sciences 2020 Scientific Sessions.
We have failed terribly at two important things. One, we are reacting to this issue only emotionally, not logically. And two, we are not asking the right questions.
WhatsApp privacy policy case is among a string of matters involving practices like restrictive platform rules, pricing & billing policies, reflecting India’s tight scrutiny of market dominance.
Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.
COMMENTS